Contracts › HT942523C0071
HT942523C0071: Medical Research and Development Contract Dha Sbir Ph Ii, Proposal No. H2S-0048, Titled: "Gw-TT2, a New Drug Product for Tinnitus"
Awarded to Gateway Biotechnology, Inc by Defense Health Agency.
$1.9Mobligated
$1.9Mpotential value
23 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0071 |
|---|---|
| Awardee | Gateway Biotechnology, Inc |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | OH |
| Offers received | 1 |
| Period of performance | 18 September 2023 to 23 August 2027 |
| Potential end | 23 August 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record